EE05538B1 - Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine - Google Patents

Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine

Info

Publication number
EE05538B1
EE05538B1 EEP200000073A EEP200000073A EE05538B1 EE 05538 B1 EE05538 B1 EE 05538B1 EE P200000073 A EEP200000073 A EE P200000073A EE P200000073 A EEP200000073 A EE P200000073A EE 05538 B1 EE05538 B1 EE 05538B1
Authority
EE
Estonia
Prior art keywords
interleukin
preparation
binding proteins
proteins
binding
Prior art date
Application number
EEP200000073A
Other languages
English (en)
Estonian (et)
Inventor
Novick Daniela
Dinarello Charles
Rubinstein Menachem
Hyun Kim Soo
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12155497A external-priority patent/IL121554A0/xx
Priority claimed from IL12163997A external-priority patent/IL121639A0/xx
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE200000073A publication Critical patent/EE200000073A/xx
Publication of EE05538B1 publication Critical patent/EE05538B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
EEP200000073A 1997-08-14 1998-08-13 Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine EE05538B1 (et)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IL12155497A IL121554A0 (en) 1997-08-14 1997-08-14 Interleukin-18 binding proteins their preparation and use
IL12163997A IL121639A0 (en) 1997-08-14 1997-08-27 Interleukin-18 binding proteins their preparation and use
IL12186097A IL121860A0 (en) 1997-08-14 1997-09-29 Interleukin-18 binding proteins their preparation and use
IL12213497A IL122134A0 (en) 1997-08-14 1997-11-06 Interleukin-18 binding proteins their preparation and use
IL12546398A IL125463A0 (en) 1997-08-14 1998-07-22 Interleukin-18 binding proteins their preparation and use
PCT/IL1998/000379 WO1999009063A1 (fr) 1997-08-14 1998-08-13 Proteines de fixation de l'interleukine-18, leur preparation et utilisation

Publications (2)

Publication Number Publication Date
EE200000073A EE200000073A (fr) 2000-10-16
EE05538B1 true EE05538B1 (et) 2012-04-16

Family

ID=27517687

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000073A EE05538B1 (et) 1997-08-14 1998-08-13 Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine

Country Status (29)

Country Link
US (4) US6605280B1 (fr)
EP (1) EP1003781B1 (fr)
JP (1) JP4272348B2 (fr)
KR (1) KR100687388B1 (fr)
CN (1) CN1243021C (fr)
AR (2) AR013422A1 (fr)
AT (1) ATE443719T1 (fr)
AU (1) AU755794B2 (fr)
BG (1) BG65519B1 (fr)
BR (1) BRPI9811940B8 (fr)
CA (1) CA2298855C (fr)
CY (1) CY1109664T1 (fr)
CZ (1) CZ300818B6 (fr)
DE (2) DE69841175D1 (fr)
DK (1) DK1003781T3 (fr)
EA (1) EA003675B1 (fr)
EE (1) EE05538B1 (fr)
ES (1) ES2149149T3 (fr)
HK (1) HK1028773A1 (fr)
HU (1) HU226698B1 (fr)
IL (5) IL121860A0 (fr)
NO (1) NO327240B1 (fr)
NZ (1) NZ502392A (fr)
PL (1) PL206070B1 (fr)
PT (1) PT1003781E (fr)
SI (1) SI1003781T1 (fr)
SK (1) SK287194B6 (fr)
UA (1) UA75862C2 (fr)
WO (1) WO1999009063A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393663B2 (en) * 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
CA2276216A1 (fr) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Peptide artificiel capable de neutraliser l'activite biologique de l'interleukine-18
EP1110969A4 (fr) * 1998-09-01 2002-01-09 Hayashibara Biochem Lab Proteine de liaison de l'interleukine 18
AR022952A1 (es) * 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
IL131047A0 (en) * 1999-07-22 2001-01-28 Yeda Res & Dev Use of il-18 inhibitors
EP1101772B1 (fr) * 1999-11-16 2009-01-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Anticorps contre le précurseur de l'interleukine-18
KR101111103B1 (ko) 2000-02-10 2012-02-13 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
TR200502508T2 (tr) * 2000-02-21 2007-04-24 Applied Research Systems Ar� Holding N.V. IL-18 İnhibitörlerinin kullanımı.
CN1250286C (zh) * 2000-05-05 2006-04-12 应用研究系统Ars股份公司 Il－18抑制剂在治疗和/或预防动脉粥样硬化中的应用
AU2005211606B2 (en) * 2000-05-05 2007-02-22 Inserm - Institut National De La Sante Et De La Recherche Medicale Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis
EP1331943A4 (fr) * 2000-10-11 2005-01-26 Viron Therapeutics Inc Molecules d'acide nucleique et polypeptides aux fins d'une immunomodulation
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
ME00549B (me) * 2001-01-29 2011-10-10 Serono Lab Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
US20030008822A1 (en) * 2001-05-16 2003-01-09 Charles Dinarello Use of IL-18 inhibitors for the treatment or prevention of sepsis
HU230294B1 (hu) * 2001-05-25 2015-12-28 Ares Trading S.A. IL-18-inhibitorok alkalmazása központi idegrendszeri sérülések kezelésére vagy megelőzésére
YU103003A (sh) 2001-06-26 2006-05-25 Abgenix Inc. Antitela za opgl
UA78516C2 (en) * 2001-08-10 2007-04-10 Applied Research Systems Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
DE60324777D1 (de) * 2002-03-22 2009-01-02 Inst Nat Sante Rech Med Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
PL376536A1 (pl) 2002-08-28 2006-01-09 Immunex Corporation Kompozycje i sposoby leczenia chorób układu sercowo-naczyniowego
ES2416510T3 (es) * 2002-10-08 2013-08-01 Ares Trading S.A. Uso de una citocina capaz de unirse a IL 18BP y de inhibir la actividad de una segunda citocina
IL152232A0 (en) * 2002-10-10 2003-05-29 Yeda Res & Dev Promoter to il-18bp, its preparation and use
AU2004235595C1 (en) 2003-04-30 2009-09-24 Japan Science And Technology Agency Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
CA2524403C (fr) 2003-05-13 2013-07-09 Applied Research Systems Ars Holding N.V. Variants actifs de la proteine de liaison il-18 et utilisations medicales de ceux-ci
ATE360647T1 (de) * 2003-11-05 2007-05-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
WO2005047478A2 (fr) * 2003-11-12 2005-05-26 The Regents Of The University Of Colorado, A Body Corporate Compositions et procedes de regulation du facteur-alpha de necrose tumorale
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
IL159670A0 (en) * 2003-12-31 2004-06-01 Yeda Res & Dev Use of il-18 binding protein in inflammations
ME01218B (fr) * 2004-03-01 2013-06-20 Ares Trading Sa Utilisation d'un milieu de culture de cellules exempt de serum et destine a la production de il-18bp dans des cellules mammiferes
WO2005097998A2 (fr) * 2004-03-31 2005-10-20 Regeneron Pharmaceuticals, Inc. Polypeptides specifiques a l'il-18 et utilisations therapeutiques associees
ATE408616T1 (de) 2004-06-29 2008-10-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
ES2376534T3 (es) 2005-06-03 2012-03-14 Merck Serono Sa Uso de isoformas de il-18bp para el tratamiento y/o prevención de enfermedades inflamatorias neurológicas.
US7691611B2 (en) * 2005-06-03 2010-04-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
JP5091127B2 (ja) * 2005-06-10 2012-12-05 アレス トレーディング ソシエテ アノニム Ｉｌ−１８結合タンパク質の精製のための方法
CN101003812B (zh) * 2006-01-17 2011-01-05 温州医学院 一种用于制备重组人egf-il18融合蛋白的方法
BRPI0711908B8 (pt) 2006-05-25 2021-05-25 Glaxo Group Ltd anticorpo anti-interleucina-18 humanizado, composição farmacêutica, uso de um anticorpo anti-interleucina 18, e, método de produção de um anticorpo.
WO2010040736A2 (fr) * 2008-10-07 2010-04-15 Ablynx Nv Séquences d’acides aminés dirigées contre le récepteur il18 et/ou il-18 et polypeptides comprenant ces séquences pour traiter des maladies et/ou des troubles associés une signalisation à médiation il-18
EP2941310A4 (fr) * 2013-01-02 2016-08-24 Wilsa Inc Procédé et appareil de conditionnement de fluides
EP3978526A1 (fr) * 2013-09-05 2022-04-06 AB2 Bio SA Protéine de liaison à l'il-18 (il-18 bp) dans des maladies inflammatoires
US10882905B2 (en) 2015-03-05 2021-01-05 Ab2 Bio Sa IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
EP3943097A1 (fr) 2020-07-24 2022-01-26 AB2 Bio SA Thérapie à base de cellules car t
WO2023143535A1 (fr) * 2022-01-28 2023-08-03 和径医药科技（上海）有限公司 Anticorps ciblant il-18bp et son utilisation
AU2023236289A1 (en) * 2022-03-15 2024-08-15 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
CN114605521A (zh) * 2022-04-06 2022-06-10 内蒙古农业大学 一种细胞免疫调节蛋白及其应用
CN114891125B (zh) * 2022-06-16 2023-04-11 广东医科大学 一种长效重组白细胞介素-18结合蛋白及其生产方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985863A (en) 1996-09-12 1999-11-16 Vertex Pharmaceuticals, Inc. Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US5776731A (en) 1996-02-21 1998-07-07 Immunex Corporation DNA encoding type-I interleukin-I receptor-like protein designated 2F1
WO1998022137A1 (fr) 1996-11-15 1998-05-28 The Kennedy Institute Of Rheumatology SUPPRESSION DU FNTα ET DE IL-12 EN THERAPIE
AU7624798A (en) 1996-12-06 1998-06-29 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1 beta converting enzyme
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
US6087116A (en) 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
SK122199A3 (en) 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
DE69835777T2 (de) 1997-08-01 2007-09-06 Serono Genetics Institute S.A. 5' EST's für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden
JP2001512012A (ja) 1997-08-01 2001-08-21 ジェンセット 精巣およびその他の組織で発現する分泌タンパク質の５’ｅｓｔ
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
CZ298597B6 (cs) 1998-04-28 2007-11-21 Applied Research Systems Ars Holding N. V. Zpusob postupné vazby polyethylenglykolových skupin na polypeptid
CA2276216A1 (fr) 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Peptide artificiel capable de neutraliser l'activite biologique de l'interleukine-18
EP1110969A4 (fr) 1998-09-01 2002-01-09 Hayashibara Biochem Lab Proteine de liaison de l'interleukine 18
AR022952A1 (es) 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
AU6078500A (en) 1999-07-09 2001-01-30 Amgen, Inc. Combination therapy for conditions leading to bone loss
WO2001019373A2 (fr) 1999-09-17 2001-03-22 Basf Aktiengesellschaft Procedes et compositions permettant de moduler la sensibilite aux corticosteroides

Also Published As

Publication number Publication date
CA2298855A1 (fr) 1999-02-25
BG104149A (en) 2000-08-31
IL121860A0 (en) 1998-02-22
SK1762000A3 (en) 2000-09-12
HUP0003533A2 (hu) 2001-01-29
EA200000216A1 (ru) 2000-08-28
IL125463A0 (en) 1999-03-12
CY1109664T1 (el) 2014-08-13
AR013422A1 (es) 2000-12-27
HU226698B1 (en) 2009-07-28
JP2001514876A (ja) 2001-09-18
KR100687388B1 (ko) 2007-02-26
IL134523A0 (en) 2001-04-30
DE69841175D1 (de) 2009-11-05
US7101689B2 (en) 2006-09-05
NZ502392A (en) 2002-12-20
HUP0003533A3 (en) 2003-08-28
SI1003781T1 (sl) 2009-12-31
NO327240B1 (no) 2009-05-18
BRPI9811940B8 (pt) 2021-07-06
PL338647A1 (en) 2000-11-06
EP1003781A1 (fr) 2000-05-31
US20060154294A1 (en) 2006-07-13
CZ2000490A3 (cs) 2000-08-16
WO1999009063A1 (fr) 1999-02-25
US6605280B1 (en) 2003-08-12
BRPI9811940B1 (pt) 2011-10-04
US20040037829A1 (en) 2004-02-26
NO20000700D0 (no) 2000-02-11
US8436148B2 (en) 2013-05-07
CN1243021C (zh) 2006-02-22
US7799541B2 (en) 2010-09-21
JP4272348B2 (ja) 2009-06-03
ES2149149T3 (es) 2009-12-01
PL206070B1 (pl) 2010-06-30
NO20000700L (no) 2000-04-14
EE200000073A (fr) 2000-10-16
CZ300818B6 (cs) 2009-08-19
ATE443719T1 (de) 2009-10-15
AU755794B2 (en) 2002-12-19
CN1267307A (zh) 2000-09-20
CA2298855C (fr) 2014-05-27
IL122134A0 (en) 1998-04-05
PT1003781E (pt) 2009-10-26
ES2149149T1 (es) 2000-11-01
AR062867A2 (es) 2008-12-10
BG65519B1 (bg) 2008-10-31
UA75862C2 (uk) 2006-06-15
AU8746098A (en) 1999-03-08
SK287194B6 (sk) 2010-03-08
IL134523A (en) 2011-09-27
EA003675B1 (ru) 2003-08-28
HK1028773A1 (en) 2001-03-02
KR20010022900A (ko) 2001-03-26
DK1003781T3 (da) 2010-01-25
US20100010200A1 (en) 2010-01-14
DE1003781T1 (de) 2001-01-11
EP1003781B1 (fr) 2009-09-23
BRPI9811940A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
EE05538B1 (et) Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine
NO983364D0 (no) Konsensusproteiner
ATA1198A (de) Snowboard - einstiegsbindung
DE69828330D1 (de) Aktiviertes Protein C Formulierungen
FI963560A (fi) Sidontamääritys, jossa käytetään häntäryhmiä sisältäviä sidonta-aineita
NO972863L (no) Skibinding
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
ATA144897A (de) Wirbelsäulen-prothese
DE69705017D1 (de) Medikamente bindendes Protein
NO995062D0 (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme
ATE262917T1 (de) Präparation umfassend thiolgruppen-haltige proteine
TR199701666A3 (tr) Sismanliga karsi proteinler
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
FI971086A (fi) Kinaasia sitova proteiini ja sen käyttö
AU1320600A (en) Human rna binding proteins
AU2003200442A1 (en) Interleukin-18 binding proteins, their preparation and use
ZA987310B (en) Interleukin-18 binding proteins, their preparation and use.
IL121639A0 (en) Interleukin-18 binding proteins their preparation and use
ID23663A (id) Persiapan kaprolaktam
SE9701041D0 (sv) Novel proteins and their use
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
ATA116597A (de) Skibindung
IL123477A0 (en) Nik binding proteins their preparation and use
DE59809617D1 (de) Skibindung